AdvertisementBrand-Name Medicines Dominate Medicare's $103 Billion Drug BillMay 01, 2015Jordan RaufacebookEmailAstraZeneca's Nexium was the top drug in Medicare Part D's spending on prescription medicines. (Bloomberg via Getty Images)
